Morningstar
AnbefaletNyt på siden Whats New Icon
Aktier

Novozymes Q2: udfordringerne fortsætter

Novozymes oplever fortsat svag organisk vækst i salget. Den organiske vækst i andet kvartal var -2 procent, som lå under konsensus, der ellers havde forventet en flad udvikling. Aktierne er nede med 4-5 procent på dagen.

Morningstar Equity Analysts 08/08/2019
Facebook Twitter LinkedIn
Font-Size


Novozymes

Af Rob Hales, CFA, aktieanalytiker hos Morningstar.

Novozymes har et svært år - primært på grund af økonomiske udfordringer i Mellemøsten og masser af regn i USA, hvilket har påvirket segmenterne for bioenergi og landbrug negativt.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

For at se denne artikel registrér dig som Morningstar Basis-medlem

Registrér dig gratis
TAGS
Facebook Twitter LinkedIn
Font-Size

Papirer nævnt i artikel

Navn på papirPrisÆndring (%)Morningstar Rating
Novozymes A/S B488,40 DKK3,47Rating

Om forfatteren

Morningstar Equity Analysts  Morningstar stock and fund analysts cover 2,000 mutual funds, 2,100 equities, and 300 exchange-traded funds.

© Copyright 2021 Morningstar, Inc. All rights reserved.

Brugervilkår        Fortrolighedspolitik       

The Morningstar Star Rating for Stocks is assigned based on an analyst's estimate of a stocks fair value. It is projection/opinion and not a statement of fact. Morningstar assigns star ratings based on an analyst’s estimate of a stock's fair value. Four components drive the Star Rating: (1) our assessment of the firm’s economic moat, (2) our estimate of the stock’s fair value, (3) our uncertainty around that fair value estimate and (4) the current market price. This process culminates in a single-point star rating that is updated daily. A 5-star represents a belief that the stock is a good value at its current price; a 1-star stock isn't. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Morningstar Star Rating for Stocks, please visit here

Quantitative Fair Value Estimate represents Morningstar’s estimate of the per share dollar amount that a company’s equity is worth today. The Quantitative Fair Value Estimate is based on a statistical model derived from the Fair Value Estimate Morningstar’s equity analysts assign to companies which includes a financial forecast of the company. The Quantitative Fair Value Estimate is calculated daily. It is a projection/opinion and not a statement of fact. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Quantiative Fair Value Estimate, please visit here

Vælg din sideudgave For at sikre, at webstedet er relevant for dig, skal vi vide, om du er en individuel investor eller en økonomisk professionel.